Halley E. Gilbert - 20 Nov 2025 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role: Director
Signature: /s/Latha Vairavan, as Attorney-in-Fact for Halley E. Gilbert
Issuer symbol: ARQT
Transactions as of: 20 Nov 2025
Net transactions value: -$363,670
Form type: 4
Filing time: 21 Nov 2025, 18:21:26 UTC
Previous filing: 16 Jun 2025
SEC: View on sec.gov

Key filing fact

Halley E. Gilbert filed Form 4 for Arcutis Biotherapeutics, Inc. (ARQT) on 21 Nov 2025.

Key facts

This page summarizes Halley E. Gilbert's Form 4 filing for Arcutis Biotherapeutics, Inc. (ARQT).
3 reported transactions and 1 derivative row are listed below.
Filing timestamp: 21 Nov 2025, 18:21.

Change

Previous filing in this sequence was filed on 16 Jun 2025.
Current net transaction value: -$363,670.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0001601360 Primary reporting owner

Gilbert Halley E

Relationship: Director
Address: C/O ARCUTIS BIOTHERAPEUTICS, INC., 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE
Signature: /s/Latha Vairavan, as Attorney-in-Fact for Halley E. Gilbert
Signature date: 21 Nov 2025

Transactions Table

ARQT transaction

Common Stock

Options Exercise

Transaction value: $91,772
Shares: +12,220
Change %: +46%
Price: $7.51
Shares after: 38,655
Date: 20 Nov 2025
Ownership: Direct
Footnotes: F1

ARQT transaction

Common Stock

Sale

Transaction value: $455,442
Shares: -16,532
Change %: -43%
Price: $27.55
Shares after: 22,123
Date: 20 Nov 2025
Ownership: Direct
Footnotes: F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

ARQT transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -12,220
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 20 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,220
Exercise price: $7.51
Footnotes: F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service.
F2	The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $27.32 to $27.72, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Content

The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023, subject to the non-employee director's continuous service.

The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $27.32 to $27.72, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.